Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC) By: Brodsky & Smith LLC via GlobeNewswire October 30, 2023 at 12:15 PM EDT BALA CYNWYD, Pa., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Eargo, Inc. (Nasdaq – EAR) Under the terms of the Merger Agreement, Eargo will be acquired by Patient Square Capital for $2.55 per share in cash for each share of Eargo held. The investigation concerns whether the Eargo Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Patient Square Capital is paying fair value to shareholders of the Company. Additional information can be found at https://www.brodskysmith.com/cases/eargo-inc-nasdaq-ear/. Miromatrix Medical, Inc. (Nasdaq – MIRO) Under the terms of the agreement, Miromatrix will be acquired by United Therapeutics Corporation (“United Therapeutics”) (Nasdaq – UTHR). United Therapeutics will commence a tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix’s development-stage, fully-implantable manufactured kidney product known as mirokidney™ by December 31, 2025. The investigation concerns whether the Miromatrix Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether United Therapeutics is paying fair value to shareholders of the Company. Additional information can be found at https://www.brodskysmith.com/cases/miromatrix-medical-inc-nasdaq-miro Physicians Realty Trust (NYSE – DOC) Under the terms of the Merger Agreement, Physicians Realty Trust will be acquired by Healthpeak Properties, Inc.(“Healthpeak”) (NYSE – PEAK). Each Physicians Realty Trust common share will be converted into 0.674 of a newly issued Healthpeak common share. Healthpeak and Physicians Realty Trust shareholders will own approximately 77% and 23% of the combined company, respectively. The investigation concerns whether the Physicians Realty Trust Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company. Additional information can be found at https://www.brodskysmith.com/cases/physicians-realty-trust-nyse-doc/. Spirit Realty Capital (NYSE – SRC) Under the terms of the agreement, Spirit Realty will be acquired by Realty Income Corporation (“Realty Income”) (NYSE – O). Spirit Realty shareholders will receive 0.762 newly-issued Realty Income common shares for each Spirit common share they own. At closing, this will result in Realty Income and Spirit Realty shareholders owning approximately 87% and 13%, respectively, of the combined company. The investigation concerns whether the Spirit Realty Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to Spirit Realty shareholders in the combined company. Additional information can be found at https://www.brodskysmith.com/cases/spirit-realty-capital-inc-nyse-src/ Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome. Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC) By: Brodsky & Smith LLC via GlobeNewswire October 30, 2023 at 12:15 PM EDT BALA CYNWYD, Pa., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Eargo, Inc. (Nasdaq – EAR) Under the terms of the Merger Agreement, Eargo will be acquired by Patient Square Capital for $2.55 per share in cash for each share of Eargo held. The investigation concerns whether the Eargo Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Patient Square Capital is paying fair value to shareholders of the Company. Additional information can be found at https://www.brodskysmith.com/cases/eargo-inc-nasdaq-ear/. Miromatrix Medical, Inc. (Nasdaq – MIRO) Under the terms of the agreement, Miromatrix will be acquired by United Therapeutics Corporation (“United Therapeutics”) (Nasdaq – UTHR). United Therapeutics will commence a tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix’s development-stage, fully-implantable manufactured kidney product known as mirokidney™ by December 31, 2025. The investigation concerns whether the Miromatrix Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether United Therapeutics is paying fair value to shareholders of the Company. Additional information can be found at https://www.brodskysmith.com/cases/miromatrix-medical-inc-nasdaq-miro Physicians Realty Trust (NYSE – DOC) Under the terms of the Merger Agreement, Physicians Realty Trust will be acquired by Healthpeak Properties, Inc.(“Healthpeak”) (NYSE – PEAK). Each Physicians Realty Trust common share will be converted into 0.674 of a newly issued Healthpeak common share. Healthpeak and Physicians Realty Trust shareholders will own approximately 77% and 23% of the combined company, respectively. The investigation concerns whether the Physicians Realty Trust Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company. Additional information can be found at https://www.brodskysmith.com/cases/physicians-realty-trust-nyse-doc/. Spirit Realty Capital (NYSE – SRC) Under the terms of the agreement, Spirit Realty will be acquired by Realty Income Corporation (“Realty Income”) (NYSE – O). Spirit Realty shareholders will receive 0.762 newly-issued Realty Income common shares for each Spirit common share they own. At closing, this will result in Realty Income and Spirit Realty shareholders owning approximately 87% and 13%, respectively, of the combined company. The investigation concerns whether the Spirit Realty Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to Spirit Realty shareholders in the combined company. Additional information can be found at https://www.brodskysmith.com/cases/spirit-realty-capital-inc-nyse-src/ Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
BALA CYNWYD, Pa., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Eargo, Inc. (Nasdaq – EAR) Under the terms of the Merger Agreement, Eargo will be acquired by Patient Square Capital for $2.55 per share in cash for each share of Eargo held. The investigation concerns whether the Eargo Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Patient Square Capital is paying fair value to shareholders of the Company. Additional information can be found at https://www.brodskysmith.com/cases/eargo-inc-nasdaq-ear/. Miromatrix Medical, Inc. (Nasdaq – MIRO) Under the terms of the agreement, Miromatrix will be acquired by United Therapeutics Corporation (“United Therapeutics”) (Nasdaq – UTHR). United Therapeutics will commence a tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix’s development-stage, fully-implantable manufactured kidney product known as mirokidney™ by December 31, 2025. The investigation concerns whether the Miromatrix Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether United Therapeutics is paying fair value to shareholders of the Company. Additional information can be found at https://www.brodskysmith.com/cases/miromatrix-medical-inc-nasdaq-miro Physicians Realty Trust (NYSE – DOC) Under the terms of the Merger Agreement, Physicians Realty Trust will be acquired by Healthpeak Properties, Inc.(“Healthpeak”) (NYSE – PEAK). Each Physicians Realty Trust common share will be converted into 0.674 of a newly issued Healthpeak common share. Healthpeak and Physicians Realty Trust shareholders will own approximately 77% and 23% of the combined company, respectively. The investigation concerns whether the Physicians Realty Trust Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company. Additional information can be found at https://www.brodskysmith.com/cases/physicians-realty-trust-nyse-doc/. Spirit Realty Capital (NYSE – SRC) Under the terms of the agreement, Spirit Realty will be acquired by Realty Income Corporation (“Realty Income”) (NYSE – O). Spirit Realty shareholders will receive 0.762 newly-issued Realty Income common shares for each Spirit common share they own. At closing, this will result in Realty Income and Spirit Realty shareholders owning approximately 87% and 13%, respectively, of the combined company. The investigation concerns whether the Spirit Realty Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to Spirit Realty shareholders in the combined company. Additional information can be found at https://www.brodskysmith.com/cases/spirit-realty-capital-inc-nyse-src/ Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.